Jazz Pharmaceuticals plc

SEC 4 · Filed

0002013156-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 26, 2026

Grant, award or other acquisition by Johnson Philip L

Security
Ordinary Shares
Code
A
Shares
11,857
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-26",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "These restricted stock units are granted pursuant to the Issuer\u0027s 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.",
    "F2": "The Reporting Person acquired 166 ordinary shares on May 30, 2025 and 140 shares on November 28, 2025 under a Section 423 Employee Stock Purchase Plan."
  },
  "owners": [
    {
      "cik": "0002013156",
      "name": "Johnson Philip L",
      "roles": [
        "officer"
      ],
      "title": "EVP \u0026 Chief Financial Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "62223",
  "price": "0.0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Ordinary Shares",
  "shares": "11857",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}